There are no items in your cart
Professor John Prins
Professor John Prins is the Acting Group Chief Executive Officer for Mater Group.
Professor John Prins is a clinician-scientist, a key opinion leader in diabetes and endocrinology in Australia and sits on numerous national and international scientific, clinical and education committees and boards.
Professor Prins undertook his clinical training in endocrinology in Brisbane and then completed a PhD in adipose tissue biology at The University of Queensland (UQ). His first postdoctoral research appointment was at the University of Cambridge, UK, based at Addenbrooke’s Hospital.
In 2004 he was Foundation/Director of the UQ Centre for Diabetes and Endocrine Research, which merged with the UQ Centre for Immunology and Cancer Research (CICR) in January 2007 to form the Diamantina Institute.
Professor Prins was appointed CEO/Director of Mater Research in 2009, and he remains actively involved in undergraduate and post-graduate teaching and training and his ongoing research interests in obesity and diabetes.
In May 2018, Professor Prins was appointed Acting Group CEO for Mater Group.